These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 23117309)
1. Serial Evaluation of Vascular Response After Implantation of a New Sirolimus-Eluting Stent With Bioabsorbable Polymer (MISTENT): an optical coherence tomography and histopathological study. Attizzani GF; Bezerra HG; Chamié D; Fujino Y; Spognardi AM; Stanley JR; Yamamoto H; Mehanna E; Wang W; Carlyle WC; McClain JB; Costa MA J Invasive Cardiol; 2012 Nov; 24(11):560-8. PubMed ID: 23117309 [TBL] [Abstract][Full Text] [Related]
2. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443 [TBL] [Abstract][Full Text] [Related]
3. Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model. Buszman PP; Michalak MJ; Pruski M; Fernandez C; Jelonek M; Janas A; Savard C; Gwiazdowska-Nowotka B; Żurakowski A; Wojakowski W; Buszman PE; Milewski K Cardiol J; 2016; 23(6):657-666. PubMed ID: 27976797 [TBL] [Abstract][Full Text] [Related]
4. Serial assessment by optical coherence tomography of early and late vascular responses after implantation of an absorbable-coating Sirolimus-Eluting stent (from the first-in-human DESSOLVE I trial). Attizzani GF; Bezerra HG; Ormiston J; Wang W; Donohoe D; Wijns W; Costa MA Am J Cardiol; 2013 Nov; 112(10):1557-64. PubMed ID: 23992957 [TBL] [Abstract][Full Text] [Related]
5. Long-term coronary arterial response to biodegradable polymer biolimus-eluting stents in comparison with durable polymer sirolimus-eluting stents and bare-metal stents: five-year follow-up optical coherence tomography study. Kuramitsu S; Sonoda S; Yokoi H; Iwabuchi M; Nishizaki Y; Shinozaki T; Domei T; Hyodo M; Inoue K; Shirai S; Ando K; Nobuyoshi M Atherosclerosis; 2014 Nov; 237(1):23-9. PubMed ID: 25190308 [TBL] [Abstract][Full Text] [Related]
6. Difference in neointimal coverage at chronic stage between bare metal stent and sirolimus-eluting stent evaluated at stent-strut level by optical coherence tomography. Ikuta S; Kobuke K; Iwanaga Y; Nakauchi Y; Yamaji K; Miyazaki S Heart Vessels; 2014 May; 29(3):320-7. PubMed ID: 23793881 [TBL] [Abstract][Full Text] [Related]
7. Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries. Sperling C; Waliszewski MW; Kherad B; Krackhardt F Ther Adv Cardiovasc Dis; 2019; 13():1753944719826335. PubMed ID: 30803407 [TBL] [Abstract][Full Text] [Related]
8. Different serial changes in the neointimal condition of sirolimus-eluting stents and paclitaxel-eluting stents: an optical coherence tomographic study. Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y; Hara M; Sakata Y; Hamasaki T; Nishino M EuroIntervention; 2014 Dec; 10(8):924-33. PubMed ID: 24602858 [TBL] [Abstract][Full Text] [Related]
9. Histological validation of frequency domain optical coherence tomography for the evaluation of neointimal formation after a novel polymer-free sirolimus-eluting stent implantation. Fu Q; Hu H; Chen W; Tan Z; Li L; Wang D; Chen B Int J Clin Exp Pathol; 2015; 8(9):11068-75. PubMed ID: 26617825 [TBL] [Abstract][Full Text] [Related]
10. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1. Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447 [TBL] [Abstract][Full Text] [Related]
11. Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography. Tada T; Byrne RA; Schuster T; Cuni R; Kitabata H; Tiroch K; Dirninger A; Gratze F; Kaspar K; Zenker G; Joner M; Schömig A; Kastrati A Cardiovasc Revasc Med; 2013; 14(2):84-9. PubMed ID: 23352095 [TBL] [Abstract][Full Text] [Related]
12. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography. Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography. Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418 [TBL] [Abstract][Full Text] [Related]
14. Comparison of neointimal coverage and extra-stent lumen between sirolimus and everolimus-eluting stent using optical coherence tomography. Oda T; Okamura T; Yamada J; Miyagi N; Uehara H; Nao T; Tateishi H; Maeda T; Nakamura T; Shiraishi K; Nakashima T; Nishimura S; Miura T; Matsuzaki M; Yano M Heart Vessels; 2016 Apr; 31(4):449-56. PubMed ID: 25614415 [TBL] [Abstract][Full Text] [Related]
15. Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice. Farooq V; Serruys PW; Heo JH; Gogas BD; Onuma Y; Perkins LE; Diletti R; Radu MD; Räber L; Bourantas CV; Zhang Y; van Remortel E; Pawar R; Rapoza RJ; Powers JC; van Beusekom HM; Garcìa-Garcìa HM; Virmani R JACC Cardiovasc Interv; 2013 May; 6(5):523-32. PubMed ID: 23702016 [TBL] [Abstract][Full Text] [Related]
16. Serial optical coherence tomography-based observation of strut coverage on drug-eluting stent crossing side-branch vessels. Lee SY; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK J Invasive Cardiol; 2012 Nov; 24(11):569-73. PubMed ID: 23117310 [TBL] [Abstract][Full Text] [Related]
17. A serial 3- and 9-year optical coherence tomography assessment of vascular healing response to sirolimus- and paclitaxel-eluting stents. Tomaniak M; Kołtowski Ł; Pietrasik A; Rdzanek A; Jąkała J; Proniewska K; Malinowski K; Mazurek T; Filipiak KJ; Brugaletta S; Opolski G; Kochman J Int J Cardiovasc Imaging; 2019 Jan; 35(1):9-21. PubMed ID: 30168010 [TBL] [Abstract][Full Text] [Related]
18. Assessment of an asymmetrical coating stent with sirolimus released from ablumial matrix in porcine model. Shen L; Wu Y; Zhang F; Wu L; Dong C; Gao Y; Sun A; Zou Y; Qian J; Sun J; Zhong W; Ge J Clin Res Cardiol; 2012 Nov; 101(11):917-27. PubMed ID: 22627890 [TBL] [Abstract][Full Text] [Related]
19. Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial. Wijns W; Vrolix M; Verheye S; Schoors D; Slagboom T; Gosselink M; Benit E; Donohoe D; Knape C; Attizzani GF; Lansky AJ; Ormiston J; EuroIntervention; 2015 Apr; 10(12):1383-90. PubMed ID: 24801119 [TBL] [Abstract][Full Text] [Related]
20. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA; JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]